Get the latest Science News and Discoveries

Beyond weight loss—how the GLP-1 story is evolving


“Imitation” drugs, unexpected benefits, serious pitfalls—here’s what comes next as GLP-1 medications continue to rise in popularity

None

Get the Android app

Or read this on Scientific American

Read more on:

Photo of Weight Loss

Weight Loss

Photo of GLP-1

GLP-1

Photo of GLP-1 story

GLP-1 story

Related news:

News photo

Wegovy may have highest eye stroke and sight loss risk of semaglutide GLP-1 agonists— Odds of ischaemic optic neuropathy(caused by inadequate/interrupted blood flow to the optic nerve, resulting in sudden vision loss in one or both eyes) nearly 5 times higher than among users of Ozempic

News photo

Holding vs continuing GLP-1/GIP agonists before upper endoscopy - EurekAlert!

News photo

What happens when patients stop taking GLP-1 drugs? New Cleveland Clinic study reveals real world insights - EurekAlert!